Personalized Physical Back Training Program to Improve Physical Functioning in People with Non-specific Low Back Pain: a Feasibility Study (LIFDI)

December 19, 2024 updated by: Universität Luzern

The aim of our clinical trial (2024-01285) is to determine how an individualized physical back training program affects physical functioning and back pain. The results will help identify the most effective treatments for low back pain. This feasibility study (2024-01284) aims to conduct a test run of the clinical trial. The main questions are:

  • Do all procedures run smoothly?
  • Does the back training program improve physical functioning?
  • Does the back training program reduce back pain?

Participants will:

  • Follow a back training program for 4 weeks.
  • Attend group exercise sessions (30 minutes per week)
  • Perform exercises at home (3x10 minutes per week).
  • Fill out a daily questionnaire on pain and exercise adherence.

Study Overview

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Luzern, Switzerland, 6002
        • University of Lucerne, Faculty of Health Sciences and Medicine, Universitäres Forschungszentrum Gesundheit und Gesellschaft

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria: Individuals who

  • have access to the University Sports of the Lucerne Universities (i.e., students, employees, alumni, subscribers),
  • report NSLBP for at least 6 weeks (e.g., no upper limit of pain duration),
  • report activity limiting NSLBP (i.e., at least one activity with a PSFS Score of ≤ 5/10 on a scale from 0 = unable to perform due to NSLBP to 10 = able to perform at the same level as before NSLBP),
  • identify NSLBP as their primary musculoskeletal complaint,
  • are between 18 and 65 years of age,
  • understand the German language,
  • are willing to participate in the study (i.e., adhere to a 4-week intervention),
  • and provide written informed consent.

Exclusion Criteria: Individuals who …

  • have been diagnosed with specific LBP (e.g., fractures, carcinoma, anomalies, nerve root affection with neurological signs such as sensitivity or reflex loss, muscle weakness, or radicular pain below the knee),
  • report red flags associated with any serious pathology or specific LBP (e.g., major trauma of the back, unintended weight loss, saddle anaesthesia, changes in bowel or bladder function associated with LBP, progressive lower extremity neurologic deficits, fever),
  • are less than 12 months post-surgery following any surgery on the lower back,
  • are on a waiting list for any surgery on the lower back,
  • are pregnant or have given birth within the last 12 months,
  • are planning to become pregnant in the next 12 months,
  • have diagnosed peripheral and/or central neurological disease,
  • have diagnosed psychological and/or psychiatric condition,
  • have diagnosed chronic toxic substances abuse (i.e., drugs, alcohol),
  • take specific medication (i.e., neuroleptics, sedatives, anti-epileptics, antidepressants),
  • are not allowed to exercise during the intervention period (e.g., on medical advice, due to a health-related condition),
  • or are expecting to be absent more than 2 weeks during the training intervention period.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Personalized physical back training program
4-week personalized physical back training program
The study intervention is a 4-week personalized physical back training program. The study intervention consists of six exercises selected from a predefined set by a physical therapist or medical doctor. These exercises are selected through a clinical reasoning process, i.e., they are tailored and problem-oriented, based on the results of a clinical assessment.
Active Comparator: Non-personalized physical back training program
4-week non-personalized physical back training program
The control intervention is a 4-week non-personalized physical back training program. The control intervention consists of six exercises selected from a predefined set by a physical therapist or medical doctor. These exercises are not selected through a clinical reasoning process, i.e., they are neither tailored nor problem-oriented nor based on the results of a clinical assessment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Logistical and operational feasibility: Response time
Time Frame: Baseline
Response time (in days).
Baseline
Logistical and operational feasibility: Recruitment capability
Time Frame: Baseline
Ratio of invited individuals to included participants.
Baseline
Logistical and operational feasibility: Sample characteristics
Time Frame: Baseline to 4 weeks
Analyze sample characteristics (e.g., gender, age) using descriptive statistics.
Baseline to 4 weeks
Logistical and operational feasibility: Data collection procedures (Access)
Time Frame: Baseline to 4 weeks
Qualitatively evaluate the access of study personnel to necessary documents and the database through interviews.
Baseline to 4 weeks
Logistical and operational feasibility: Data collection procedures (Questionnaire)
Time Frame: Baseline to 4 weeks
Qualitatively evaluate the usability of the questionnaire through interviews.
Baseline to 4 weeks
Logistical and operational feasibility: Data collection procedures (Clinical Assessment)
Time Frame: Baseline to 4 weeks
Qualitatively evaluate the usability of the clinical assessment through interviews.
Baseline to 4 weeks
Logistical and operational feasibility: Acceptability and suitability of the intervention and study procedures
Time Frame: Baseline to 4 weeks
Qualitatively assess the acceptability and suitability of the intervention and study procedures through interviews.
Baseline to 4 weeks
Logistical and operational feasibility: Resource management
Time Frame: Baseline to 4 weeks
Qualitatively evaluate the time and personnel required for conducting the study through interviews.
Baseline to 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-rated physical functioning (PSFS)
Time Frame: Baseline to 4 weeks
Change in Patient-specific Functional Scale (PSFS), most bothersome activity. Range from 0 (unable to perform due to NSLBP) to 10 (able to perform at the same level as before NSLBP).
Baseline to 4 weeks
Self-rated physical functioning (RMDQ)
Time Frame: Baseline to 4 weeks
Change in Roland Morris Disability Questionnaire (RMDQ). Range from 0 (no disability) to 24 (maximum disability).
Baseline to 4 weeks
Health-related quality of life (EQ-VAS)
Time Frame: Baseline to 4 weeks
Change in EQ Visual Analogue Scale (EQ-VAS). Range from 0 (lowest health-related quality of life) to 100 (highest health-related quality of life).
Baseline to 4 weeks
Health-related quality of life (EQ-5D-5L)
Time Frame: Baseline to 4 weeks
Change in 5-Level EuroQoL5D version (EQ-5D-5L). Range from 0 (lowest health-related quality of life) to 1 (highest health-related quality of life).
Baseline to 4 weeks
Pain intensity (NRS)
Time Frame: Baseline to 4 weeks
Change in pain intensity (11-point Numeric Rating Scale, NRS). Range from 0 (no pain) to 10 (pain as bad as you can imagine). Recall period: 7 days.
Baseline to 4 weeks
Intervention-related (serious) adverse events
Time Frame: During the 4 week intervention period
Number of serious adverse events (SAE) and adverse events (AE) that are deemed possibly, probably, or definitely related to the intervention (according to ClinO, Art. 63, Switzerland).
During the 4 week intervention period

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain frequency
Time Frame: Baseline to 4 weeks
Change in number of episodes with NSLBP. Numerically, with 0 = minimum. Recall period: 7 days.
Baseline to 4 weeks
Pain duration
Time Frame: Baseline to 4 weeks
Change in pain duration (e.g., average duration of an episode of NSLBP within the last 7 days). In minutes, hours, or days, with 0 = minimum. Recall period: 7 days.
Baseline to 4 weeks
Pain interference (PEG)
Time Frame: Baseline to 4 weeks
Change in Pain, Enjoyment, and General Activity (PEG) 3-Item Scale. Range from 0 (no pain; does not interfere) to 10 (pain as bad as you can imagine; completely interferes). Recall period: 7 days.
Baseline to 4 weeks
Pain extent
Time Frame: Baseline to 4 weeks
Change in pain extent. Percentages of the body with NSLBP, with 0%=minimum
Baseline to 4 weeks
Performance-based physical functioning (pressure pain threshold)
Time Frame: Baseline to 4 weeks
Change in pressure pain threshold. kPA, with 0=minimum
Baseline to 4 weeks
Performance-based physical functioning (range of motion)
Time Frame: Baseline to 4 weeks
Change in range of motion. Degrees, with 0=minimum
Baseline to 4 weeks
Performance-based physical functioning (strength)
Time Frame: Baseline to 4 weeks
Change in strength. Nm, with 0=minimum
Baseline to 4 weeks
Performance-based physical functioning (neurodynamics)
Time Frame: Baseline to 4 weeks
Change in neurodynamics. Positive, negative.
Baseline to 4 weeks
Performance-based physical functioning (movement control)
Time Frame: Baseline to 4 weeks
Change in movement control. Positive, negative.
Baseline to 4 weeks
NSLBP-related work productivity loss
Time Frame: Baseline to 4 weeks
Change in Work Productivity and Activity Impairment Questionnaire (WPAI). Percentages, with 0%=no work productivity loss.
Baseline to 4 weeks
Participant satisfaction
Time Frame: Baseline to 4 weeks
Change in participant satisfaction (e.g., 1) I am satisfied with the training program I received. 2) I am satisfied with the result of the training program). 5-point Likert scale (strongly agree, agree, uncertain, disagree, strongly disagree).
Baseline to 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Claudio Perret, Prof., University of Lucerne, Faculty of Health Sciences and Medicine, Universitäres Forschungszentrum Gesundheit und Gesellschaft, Frohburgstrasse 3, 6002 Luzern

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 2, 2024

Primary Completion (Actual)

December 19, 2024

Study Completion (Actual)

December 19, 2024

Study Registration Dates

First Submitted

July 19, 2024

First Submitted That Met QC Criteria

August 2, 2024

First Posted (Actual)

August 6, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 19, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2024-01284
  • 63674 (Other Grant/Funding Number: Stiftung Universität Luzern)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The investigators plan to make encrypted individual participant data (IPD) available through a repository and/or via publications, such as supplementary materials

IPD Sharing Time Frame

Data will be available from the completion of the study for at least 10 years.

IPD Sharing Access Criteria

Access to the data will be granted according to the repository and/or publisher's criteria.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Personalized physical back training program

Subscribe